Live feed
Filing
SC 13G
SC 13G0000902664-16-008097·Adamas Pharmaceuticals Inc
Schedule 13G ownership disclosure
ADAMAS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00548A106
Event date: 2016-09-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,153,022
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-16-008097
- Form type
- SC 13G
- Filer
- Adamas Pharmaceuticals Inc
- CIK
- CIK 1328143
- Filed
- Sep 12, 2016
- Reporting period
- Sep 02, 2016
- Description
- Schedule 13G beneficial ownership